Form 8-K - Current report:
SEC Accession No. 0001140361-22-044533
Filing Date
2022-12-06
Accepted
2022-12-06 08:00:26
Documents
12
Period of Report
2022-12-01
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K brhc10045110_8k.htm   iXBRL 8-K 54469
  Complete submission text file 0001140361-22-044533.txt   192692

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA galt-20221201.xsd EX-101.SCH 3902
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE galt-20221201_lab.xml EX-101.LAB 22547
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE galt-20221201_pre.xml EX-101.PRE 16069
6 EXTRACTED XBRL INSTANCE DOCUMENT brhc10045110_8k_htm.xml XML 4244
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31791 | Film No.: 221446719
SIC: 2834 Pharmaceutical Preparations